CVS Health Corporation (CVS)
CVS Health (CVS) Suffers a Larger Drop Than the General Market: Key Insights
CVS Health (CVS) closed at $79.79 in the latest trading session, marking a -1.13% move from the prior day.
Here is What to Know Beyond Why CVS Health Corporation (CVS) is a Trending Stock
Recently, Zacks.com users have been paying close attention to CVS Health (CVS). This makes it worthwhile to examine what the stock has in store.
Looking for Stocks with Positive Earnings Momentum? Check Out These 2 Medical Names
The Zacks Earnings ESP is a great way to find potential earnings surprises. Why investors should take advantage now.
CVS Health (CVS) Beats Stock Market Upswing: What Investors Need to Know
The latest trading day saw CVS Health (CVS) settling at $79.12, representing a +1.38% change from its previous close.
3 Monthly Dividend ETFs That Are Must-Buys Right Now
Inflation is still eating away at people's budgets, as only the pace has slowed, that too at a snail's pace.
Is Trending Stock CVS Health Corporation (CVS) a Buy Now?
Zacks.com users have recently been watching CVS Health (CVS) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.
CVS Stock Gains From Offering MMR Vaccine to South Carolina Residents
CVS Health shares jump after the company begins offering MMR vaccines across South Carolina pharmacies and clinics post a measles outbreak.
Top Wall Street analysts are upbeat on these 3 dividend stocks for enhanced returns
TipRanks' ranking service discusses three dividend-paying stocks, including Devon Energy and CVS Health.
Why CVS Health (CVS) is a Top Momentum Stock for the Long-Term
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Buy Or Fear CVS Stock At $78?
CVS Health's (NYSE: CVS) latest results affirm several points: their sales and adjusted profits remain stable, and they are adjusting their forecasts upward. Nonetheless, the quality of their profits and elevated debt still render the stock a “cheap but risky” option, rather than a definitive bargain.
CVS Health Hikes Its Outlook, and Says It Plans to Roll Out AI Platform
CVS wants investors to know it sees bigger profits ahead, and has new AI plans.
CVS Health: Investor Day Targets Set Attractive Baseline For 2026
CVS Health is positioned for continued outperformance, with a strong turnaround driving industry-leading results and a reiterated "Buy" rating. CVS's Q3 showed 7.8% revenue growth, 47% adjusted EPS growth, and significant margin improvement, reversing prior underperformance versus peers. Investor Day guidance signals robust EPS growth through 2028, led by Healthcare Benefits and a focus on profitability over aggressive expansion.
